Summary
Garrett Ginell is an investment associate at Alexandria Venture Investments with a decade of experience bridging computational biophysics research and early-stage life science commercialization. He holds a PhD in Biochemistry/Biophysics and built computational, bioinformatic, and AI/ML tools to dissect protein disorder, phase separation, and sequence-driven interactions—work that informed advances in neurodegeneration, synthetic biology, and therapeutic delivery. Garrett has transitioned his deep technical expertise into venture diligence and NewCo formation, advising and de-risking science for investors and founders at Breakout Ventures, Momentum BioInnovation, and through hands-on postdoctoral and consulting roles. Based in St. Louis, he combines a researcher's fluency in mechanistic protein science with practical deal and operational experience, making him adept at spotting platform technologies with clear patient impact. An underappreciated strength is his track record of translating niche theoretical insights into tangible commercial hypotheses that accelerate translational programs.
10 years of coding experience
3 years of employment as a software developer
Bachelor of Arts (B.A.), Biochemistry and Molecular Biology, Bachelor of Arts (B.A.), Biochemistry and Molecular Biology at Cornell College
Doctor of Philosophy - PhD, Biochemistry, Biophysics and Molecular Biology, Doctor of Philosophy - PhD, Biochemistry, Biophysics and Molecular Biology at Washington University in St. Louis
Neuqua Valley High School
English, French